Sol Gel Technologies Ltd. (SLGL) PT Raised to $110 at H.C. Wainwright Jan 20, 2026 06:41AM
Sol Gel Technologies Ltd. (SLGL) PT Raised to $50 at H.C. Wainwright Oct 27, 2025 06:49AM
Sol-Gel receives Health Canada approval for EPSOLAY rosacea treatment Sep 4, 2025 07:02AM
Sol-Gel Technologies Ltd. (SLGL) Misses Q2 EPS by 90c Aug 15, 2025 04:59PM
Sol-Gel Technologies Ltd. (SLGL) Announces 10-for-1 Reverse Share Split May 1, 2025 07:09AM


Apr 17, 2025 08:42AM Sol-Gel Technologies Ltd. (SLGL) sells U.S. rights for EPSOLAY and TWYNEO
Nov 20, 2024 07:02AM Sol-Gel Technologies Ltd. (SLGL) Announces 180-Day Extension to Regain Compliance with Nasdaq Minimum Bid Requirement
Aug 16, 2024 12:36PM Sol-Gel Technologies Ltd. (SLGL) Misses Q2 EPS by 2c
Jul 25, 2024 07:03AM Sol-Gel Technologies (SLGL) Announces Signing of Six Exclusive License Agreements to Commercialize TWYNEO and EPSOLAY in Europe and South Africa
Jul 15, 2024 07:01AM Sol-Gel Technologies Ltd. (SLGL) Announces Management Change